• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Arrowhead Pharma (NQ: ARWR )

    21.39 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Arrowhead Pharma

    < Previous 1 2 3 4 5 Next >
    Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
    The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma. 
    Via Investor's Business Daily
    ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024
    ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
    A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides. 
    Via Investor's Business Daily
    Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma
    Via Benzinga
    Recap: Arrowhead Pharma Q1 Earnings
    Via Benzinga
    Earnings Scheduled For February 6, 2024
    Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
    Via Benzinga
    Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
    Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025. 
    Via InvestorPlace
    Why Arrowhead Pharmaceuticals (ARWR) Stock Is Seeing Blue Skies
    Arrowhead Pharmaceuticals shares are trading higher by more than 6% during Monday's session. The company announced that it presented preclinical data on ARO-INHBE. 
    Via Benzinga
    5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
    Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
    Via Benzinga
    Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?
    Arrowhead Pharmaceuticals announced Phase 3 PALISADE study results showing significant triglyceride reduction in familial chylomicronemia syndrome patients treated with plozasiran. 
    Via Benzinga
    Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
    These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet. 
    Via InvestorPlace
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024
    ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
    Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses... 
    Via Benzinga
    The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
    With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April. 
    Via InvestorPlace
    NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling
    The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation. 
    Via InvestorPlace
    The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
    The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride. 
    Via InvestorPlace
    EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 Oversold Russell 2000 Stocks to Add to Your February Buy List
    Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong. 
    Via InvestorPlace
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
    Via Investor's Business Daily
    7 Biotech Stocks Fighting America’s Deadliest Diseases
    Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
    Via Investor's Business Daily
    Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. 
    Via Benzinga
    Why Arrowhead Pharmaceuticals Shares Are Moving
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.